Coloplast Overview

  • Year Founded
  • 1954

Year Founded

  • Status
  • Public

  • Employees
  • 17,775

Employees

  • Stock Symbol
  • COLO B

Stock Symbol

  • Investments
  • 15

  • Share Price
  • $73.86
  • (As of Wednesday Closing)

Coloplast General Information

Description

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Contact Information

Formerly Known As
Dansk Coloplast
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Holtedam 1-3
  • 3050 Humlebaek
  • Denmark
+45 49
Primary Industry
Medical Supplies
Other Industries
Monitoring Equipment
Surgical Devices
Stock Exchange
CSE
Corporate Office
  • Holtedam 1-3
  • 3050 Humlebaek
  • Denmark
+45 49

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Coloplast Stock Performance

As of 18-Nov-2026, Coloplast’s stock price is $73.86. Its current market cap is $16.6B with 225M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$73.86 $74.73 $56.30 - $91.70 $16.6B 225M 378K $2.12

Coloplast Financials Summary

As of 30-Sep-2026, Coloplast has a trailing 12-month revenue of $4.5B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Sep-2026 FY 2025 30-Sep-2025 FY 2024 30-Sep-2024
EV 17,774,280 17,774,280 22,923,071 33,033,977
Revenue 4,499,827 4,499,827 4,121,050 3,929,110
EBITDA 1,386,129 1,386,129 1,232,441 1,221,033
Net Income 477,954 477,954 537,567 734,364
Total Assets 7,019,005 7,019,005 7,601,098 7,200,470
Total Debt 3,264,280 3,264,280 3,557,823 3,389,417
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Coloplast Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Coloplast‘s full profile, request access.

Request a free trial

Coloplast Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and m
Medical Supplies
Humlebaek, Denmark
17,775 As of 2026

Watford, United Kingdom
 

Alpharetta, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Coloplast Competitors (22)

One of Coloplast’s 22 competitors is Smith & Nephew, a Corporation company based in Watford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Smith & Nephew Corporation Watford, United Kingdom
Avanos Medical Private Equity-Backed Alpharetta, GA
Aspen Surgical Products Private Equity-Backed Caledonia, MI
Kimal Formerly Accelerator/Incubator backed Worcester, United Kingdom
Medtronic Corporation Minneapolis, MN
You’re viewing 5 of 22 competitors. Get the full list »

Coloplast Patents

Coloplast Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1152011-S1 Adhesive nose patch Active 22-May-2025
WO-2026228884-A1 An ostomy appliance liner assembly and a method of removing Pending 02-May-2025
WO-2026223871-A1 A heat and moisture exchanging (hme) device Pending 23-Apr-2025
WO-2026184827-A1 A sleeve, an anal irrigation device and a kit of parts Pending 07-Mar-2025
WO-2026162112-A1 A urinary catheter and a connector with pressure equalization Pending 29-Jan-2025 A61M25/0017
To view Coloplast’s complete patent history, request access »

Coloplast Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Coloplast Investments & Acquisitions (15)

Coloplast’s most recent deal was a Merger/Acquisition with Uromedica for . The deal was made on 18-Feb-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Uromedica 18-Feb-2026 Merger/Acquisition Therapeutic Devices
Francis Medical 16-Dec-2024 Later Stage VC Surgical Devices
Kerecis 31-Aug-2023 Merger/Acquisition Drug Discovery
Atos Medical 08-Nov-2021 Merger/Acquisition Therapeutic Devices
Francis Medical 15-Sep-2021 Early Stage VC Surgical Devices
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Coloplast ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

17.71 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Supplies

Subindustry

of 60

Rank

Percentile

To view Coloplast’s complete esg history, request access »

Coloplast Exits (2)

Coloplast’s most recent exit was on 01-Jun-2006 from Mills Biopharmaceuticals. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Mills Biopharmaceuticals 01-Jun-2006 Completed
Amoena 01-Jan-1996 Merger/Acquisition Completed
To view Coloplast’s complete exits history, request access »

Coloplast Affiliates

Subsidiaries (18)

Name Industry Location Year Founded
Coloplast Finance Dk Humlebæk, Netherlands 2022
Atos Medical Holding Malmo, Sweden 2016
ATOS MEDICAL France Bagneux, France 2010
Comfort Medical Coral Springs, FL 2010
Coloplast Business Centre Szczecin, Poland 2009
You’re viewing 5 of 18 affiliates. Get the full list.  »

Coloplast FAQs

  • When was Coloplast founded?

    Coloplast was founded in 1954.

  • Where is Coloplast headquartered?

    Coloplast is headquartered in Humlebaek, Denmark.

  • What is the size of Coloplast?

    Coloplast has 17,775 total employees.

  • What industry is Coloplast in?

    Coloplast’s primary industry is Medical Supplies.

  • Is Coloplast a private or public company?

    Coloplast is a Public company.

  • What is Coloplast’s stock symbol?

    The ticker symbol for Coloplast is COLO B.

  • What is the current stock price of Coloplast?

    As of 18-Nov-2026 the stock price of Coloplast is $73.86.

  • What is the current market cap of Coloplast?

    The current market capitalization of Coloplast is $16.6B.

  • What is Coloplast’s current revenue?

    The trailing twelve month revenue for Coloplast is $4.5B.

  • Who are Coloplast’s competitors?

    Smith & Nephew, Avanos Medical, Aspen Surgical Products, Kimal, and Medtronic are some of the 22 competitors of Coloplast.

  • What is Coloplast’s annual earnings per share (EPS)?

    Coloplast’s EPS for 12 months was $2.12.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process